Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by A. Ring
Baugeschichte beim Weihnachts-Special der „Freien Presse“ im Freiberger Pressehaus zu entdecken
Redaktion und Geschäftsstelle der „Freien Presse“ laden zum Weihnachts-Special ein. Zum Programm gehören auch Rundgänge durch das Haus. Bestsellerautorin Sabine Ebert ist zu Gast. Wenn sich am Freitag, 12. Dezember, um 14 Uhr die Türen zum Weihnachts-Special der Lokalredaktion Freiberg der „Freien Presse“ öffnen, sind sowohl die Leserinnen und Leser von Sachsens größter Tageszeitung, als auch andere Interessierte eingeladen.
Adjuvant Chemotherapy for Breast Cancer in Older Women: An Analysis of Retrospective English Cancer Registration Data
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Fig 1 Consort diagram of patients included in the analysis. Fig 2 Treatment received by age at diagnosis for patients with stage I-III (or unknown stage). Fig 3 Patients aged 70–79 years treated surgically who received adjuvant chemotherapy, by year of diagnosis.
Exercise exertion protocol in testing and treating concussion - A case study
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Introduction: The consensus statement on concussion in sport reflects the current state of knowledge and is modified as new knowledge develops. It gives best practice guidelines on the management of sport-related concussion (SRC) using an expert consensus-based approach.
Clinical Benefit from Vinorelbine after Prior Treatment with Eribulin: a Single-centre Experience
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Purpose: The EMBRACE trial demonstrated that eribulin, a microtubule inhibitor, improved survival for previously treated advanced breast cancer (ABC) compared with chemotherapy of physician’s choice, which was vinorelbine, a vinca alkaloid microtubule inhibitor, in 25% [1].
Capecitabine monotherapy in patients aged 70 years and older with metastatic breast cancer (MBC)
Background: Capecitabine monotherapy is associated with a clinical benefit rate (CBR) of 60% and a median time to progression (TTP) of 4 months in patients ?65 years (yrs) with MBC. However, 30% require a dose reduction (DR) due to toxicity. At the Royal Marsden Hospital, the starting dose and schedule for capecitabine is 2000mg/m2 on days 1-14, every 3 weeks.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with A.
Contact A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack